President and Chief Executive Officer, Director
David Burgstahler has been a Director since our inception and our President and Chief Executive Officer since February 12, 2021. Mr. Burgstahler is a Managing Partner and Chief Executive Officer of Avista Capital Partners and has served in various capacities at Avista since its founding in 2005.
Prior to forming Avista, he was a Partner of DLJMB from 2004 to 2005 and served in various capacities at DLJMB and its affiliates from 1995 to 2005. Prior to DLJMB, Mr. Burgstahler worked at Andersen Consulting (now known as Accenture) and McDonnell Douglas (now known as Boeing).
Mr. Burgstahler currently serves as a Director of Cosette Pharmaceuticals, RVL Pharmaceuticals (Nasdaq: RVLP), United BioSource Corporation, XIFIN and other private boards. He previously served on the boards of AngioDynamics (Nasdaq: ANGO), Arcadia Consumer Healthcare, Armored AutoGroup, BioReliance, ConvaTec Group, Focus Diagnostics, INC Research Holdings (Nasdaq: INCR), Inform Diagnostics, Lantheus Holdings (Nasdaq: LNTH), MPI Research, Inc., Strategic Partners, Visant, Warner Chilcott (Nasdaq: WCRX) and WideOpenWest (NYSE: WOW).
Mr. Burgstahler received a B.S. in Aerospace Engineering from the University of Kansas and an M.B.A. from Harvard Business School. We believe that Mr. Burgstahler’s extensive experience serving as a director for a diverse group of private and public companies, including those in the healthcare industry, makes him well-qualified to serve as a member of our board of directors.